Search Results

There are 14358 results for: content related to: Empowering Students to Create and Claim Value through the Thomas–Kilmann Conflict Mode Instrument

  1. You have full text access to this OnlineOpen article
    Subsequent treatment of epidermal growth factor receptor-tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma

    Thoracic Cancer

    Volume 6, Issue 6, November 2015, Pages: 678–686, Xiaojuan Qiao, Ye Zhang, Jinghui Wang, Jingying Nong, Xi Li, Xinjie Yang, Jialin Lv, Hui Zhang, Na Qin, Quan Zhang, Wentao Yue and Shucai Zhang

    Version of Record online : 12 FEB 2015, DOI: 10.1111/1759-7714.12236

  2. Do we need more drugs for chronic myeloid leukemia?

    Immunological Reviews

    Volume 263, Issue 1, January 2015, Pages: 106–123, Tessa L. Holyoake and G. Vignir Helgason

    Version of Record online : 15 DEC 2014, DOI: 10.1111/imr.12234

  3. You have free access to this content
    Structural basis for dual inhibitory role of tamarind Kunitz inhibitor (TKI) against factor Xa and trypsin

    The FEBS Journal

    Volume 279, Issue 24, December 2012, Pages: 4547–4564, Dipak N. Patil, Anshul Chaudhary, Ashwani K. Sharma, Shailly Tomar and Pravindra Kumar

    Version of Record online : 22 NOV 2012, DOI: 10.1111/febs.12042

  4. You have free access to this content
    Impact of tyrosine kinase inhibitors on the incidence of brain metastasis in metastatic renal cell carcinoma

    Cancer

    Volume 117, Issue 21, 1 November 2011, Pages: 4958–4965, Jonathan Verma, Eric Jonasch, Pamela Allen, Nizar Tannir and Anita Mahajan

    Version of Record online : 11 APR 2011, DOI: 10.1002/cncr.26138

  5. You have free access to this content
    Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era

    Cancer

    Volume 118, Issue 14, 15 July 2012, Pages: 3571–3578, Ryan S. Turley, Peter D. Peng, Srinevas K. Reddy, Andrew S. Barbas, David A. Geller, J. Wallis Marsh, Allan Tsung, Timothy M. Pawlik and Bryan M. Clary

    Version of Record online : 15 NOV 2011, DOI: 10.1002/cncr.26650

  6. You have free access to this content
    Lung Cancer

    Respirology

    Volume 20, Issue S3, December 2015, Pages: 87–103,

    Version of Record online : 3 DEC 2015, DOI: 10.1111/resp.12706_10

  7. Enzyme- and Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase Inhibitors

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 12, December 2014, Pages: 3810–3833, Jie Shao, John S. Markowitz, Di Bei and Guohua An

    Version of Record online : 10 OCT 2014, DOI: 10.1002/jps.24113

  8. A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 4, August 2015, Pages: 391–397, A.-S. Lang, M. Mounier, M. Roques, M. L. Chretien and M. Boulin

    Version of Record online : 10 APR 2015, DOI: 10.1111/jcpt.12273

  9. You have free access to this content
    Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is effective as first-line treatment of advanced non-small-cell lung cancer with mutated EGFR: A meta-analysis from six phase III randomized controlled trials

    International Journal of Cancer

    Volume 131, Issue 5, 1 September 2012, Pages: E822–E829, Guanghui Gao, Shengxiang Ren, Aiwu Li, Jianfang Xu, Qinghua Xu, Chunxia Su, Jian Guo, Qinfang Deng and Caicun Zhou

    Version of Record online : 27 JAN 2012, DOI: 10.1002/ijc.27396

  10. Tyrosine kinase inhibitor-induced vasculopathy in clear cell renal cell carcinoma: an unrecognized antitumour mechanism

    Histopathology

    Volume 64, Issue 4, March 2014, Pages: 484–493, Toyonori Tsuzuki, Naoto Sassa, Yoshie Shimoyama, Takamitsu Morikawa, Ryoichi Shiroki, Makoto Kuroda, Akitoshi Fukatsu, Kyoko Kuwahara, Yasushi Yoshino, Ryohei Hattori and Momokazu Gotoh

    Version of Record online : 26 NOV 2013, DOI: 10.1111/his.12277

  11. You have free access to this content
    Molecular monitoring to improve outcomes in patients with chronic myeloid leukemia in chronic phase: Importance of achieving treatment-free remission

    American Journal of Hematology

    Volume 90, Issue 3, March 2015, Pages: 242–249, Harry P. Erba

    Version of Record online : 30 JAN 2015, DOI: 10.1002/ajh.23902

  12. You have free access to this content
    Targeting survival pathways in chronic myeloid leukaemia stem cells

    British Journal of Pharmacology

    Volume 169, Issue 8, August 2013, Pages: 1693–1707, A Sinclair, A L Latif and T L Holyoake

    Version of Record online : 26 JUL 2013, DOI: 10.1111/bph.12183

  13. You have free access to this content
    Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor

    Cancer

    Volume 119, Issue 24, 15 December 2013, Pages: 4325–4332, Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka, Jumpei Takeshita, Kosuke Tanaka, Shigeki Nanjo, Shiro Fujita, Reiko Kaji, Yukihiro Imai, Kazuya Monden, Takeshi Matsumoto, Kazuma Nagata, Kyoko Otsuka, Ryo Tachikawa, Keisuke Tomii, Kei Kunimasa, Masahiro Iwasaku, Akihiro Nishiyama, Tadashi Ishida and Yoshihiro Nishimura

    Version of Record online : 16 SEP 2013, DOI: 10.1002/cncr.28364

  14. You have free access to this content
    Implementation of modern therapy approaches and research for non-small cell lung cancer in Japan

    Respirology

    Volume 20, Issue 2, February 2015, Pages: 199–208, Yoichi Nakanishi

    Version of Record online : 16 JAN 2015, DOI: 10.1111/resp.12460

  15. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour

    ANZ Journal of Surgery

    Volume 84, Issue 12, December 2014, Pages: E1–E8, Ferdinando C. M. Cananzi, Ajay P. Belgaumkar, Bruno Lorenzi and Satvinder Mudan

    Version of Record online : 6 MAY 2013, DOI: 10.1111/ans.12195

  16. You have full text access to this OnlineOpen article
    Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors

    Thoracic Cancer

    Volume 7, Issue 2, March 2016, Pages: 161–166, Sung Hoon Sim, Seung-Hoon Beom, Yong-Oon Ahn, Bhumsuk Keam, Tae Min Kim, Se-Hoon Lee, Dong-Wan Kim and Dae Seog Heo

    Version of Record online : 28 AUG 2015, DOI: 10.1111/1759-7714.12304

  17. A comparison between patients with gastrointestinal stromal tumours diagnosed with isolated liver metastases and liver metastases plus sarcomatosis

    HPB

    Volume 15, Issue 9, September 2013, Pages: 655–660, Sebastian G. de la Fuente, Jeremiah L. Deneve, Colin M. Parsons, Jonathan S. Zager, Anthony P. Conley and Ricardo J. Gonzalez

    Version of Record online : 27 DEC 2012, DOI: 10.1111/hpb.12011

  18. You have full text access to this Open Access content
    Epidermal growth factor receptor mutation-guided treatment for lung cancers: Where are we now?

    Thoracic Cancer

    Volume 2, Issue 1, February 2011, Pages: 1–6, Zengliu Su

    Version of Record online : 1 FEB 2011, DOI: 10.1111/j.1759-7714.2010.00035.x

  19. You have free access to this content
    Cardiovascular Toxicities of Small Molecule Tyrosine Kinase Inhibitors: An Opportunity for Systems-Based Approaches

    Clinical Pharmacology & Therapeutics

    Volume 101, Issue 1, January 2017, Pages: 65–80, S-A Brown, L Nhola and J Herrmann

    Version of Record online : 26 NOV 2016, DOI: 10.1002/cpt.552

  20. You have free access to this content
    Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring

    American Journal of Hematology

    Volume 91, Issue 2, February 2016, Pages: 252–265, Elias Jabbour and Hagop Kantarjian

    Version of Record online : 22 JAN 2016, DOI: 10.1002/ajh.24275